Company Overview: ADMA Biologics, Inc

About the Company

ADMA Biologics, Inc

ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons.


ADMA also operates ADMA BioCenters, an FDA-licensed source plasma collection facility which provides a portion of blood plasma for the manufacture of the Company’s lead product candidate

Investor Toolkit

Company News

Email Subscription


Follow this blog

Get every new post delivered right to your inbox.

Email address